Dendritic cells produce eicosanoids, which modulate generation and functions of antigen-presenting cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 66, Issue 5-6, 2002, Pages 459-466

  Harizi, H ^a   Gualde, N ^a  

^a CNRS Bordeaux Segalen University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ICOSANOID; LEUKOTRIENE B4; PROSTAGLANDIN E2;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DENDRITIC CELL; ICOSANOID METABOLISM; IMMUNOREGULATION; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS); MURINAE;

EID: 0036586660     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0383     Document Type: Article

References (58)

1. Zimpfer U., Dichmann S., Termeer C. C., Simon J. C., Schroder J. M., Norgauer J. Human dendritic cells are physiological source of the chemotactic arachidonic acid metabolite 5-oxo-eicosatetraenoic acid. Inflamm Res 2000; 49: 633-638.
2. Goodwin J. S., Webb D. R. Regulation of immune response by prostaglandins. Clin Immunol Immunopathol 1980; 15: 106-122.
3. Kuehl F. A., Egan R. W. Prostaglandin, arachidonic acid, and inflammation. Science 1980; 210: 978-984.
4. Leung K. H., Mihich E. Prostaglandins modulation of development of cell mediated immunity in culture. Nature 1980; 130: 1495-1497.
5. Gualde N., Aldigier J. C., Mexmain S., Goodwin J. S. Regulation of immune response by eicosanoids acids. In: Goodwin J. S., ed. Prostaglandins and Immunity. Boston: Martinus Nijhoff, 1985; 147-160.
6. Juzan M., Hostein I., Gualde N. Role of thymus-eicosanoids in the immune response. Prostaglandins Leukot Essent Fatty Acids 1992; 46: 247-255.
7. Denisot Y., Dulery C., Trimoreau F., Desplat V., Praloran V. Arachidonic acid and human bone marrow stromal cells. Biochim Biophys Acta 1998; 1402: 209-215.
8. Whittaker D. S., Bahjat K. S., Moldawer L. L., Clare-Salzler M. J. Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2 mediated prostanoid production. J Immunol 2000; 165: 4298-4304.
9. Doig M. V., Ford-Hutchinson A. W. The production and characterization of products of 5-lipoxygenase enzyme system released by rat peritoneal macrophages. Prostaglandin 1980; 20: 1007-1019.
10. 2 from human monocytes stimulated with aggregated IgG, IgA and IgE. J Immunol 1986; 136: 4188-4193.
11. Aderem A. A., Cohen D. S., Rwright S. D., Cohen Z. A. Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J Exp Med 1986; 164: 165-179.
12. Kurland J. I., Bockman R. Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med 1978; 147: 952-955.
13. Steinman R. M. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991; 9: 271-296.
14. Steinman R. M., Inaba K., Turley S., Pierre P., Mellman I. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum Immunol 1999; 60: 562-567.
15. Avigan D. Dendritic cells: development, function and potential use for cancer immunotherapy. Blood Rev 1999; 13: 51-64.
16. Banchereau J., Steinman R. M Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
17. Cella M., Sallusto F., Lanzavecchia A. Origin maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9: 10-16.
18. Chong-Jeh Lo, Gill Cryer M. D. H., Minjuan-Fu M. D., Rosa Lo F. Regulation of macrophage eicosanoid generation is dependent on nuclear factor kB. J Trauma: Injury Infect Crit Care 1998; 45: 19-24.
19. 2 that contributes to the immunomodulation induced by antigen-presenting cells. Cell Immunol 2001; 209: 19-28.
20. Smith W. L., Meade E. A., DeWitt D. L. Pharmacology of prostaglandin endoperoxide synthase isoenzymes-1 and -2. Ann NY Acad Sci 1994; 714: 136-142.
21. Masferrer J. L., Reddy S. T., Zweifel B. S. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. Exp Ther 1994; 270: 1340-1344.
22. Ford-Hutchinson A. W. Leukotriene B4 in inflammation. Crit Rev Immunol 1991; 10: 1-12.
23. Smith M. J. H., Ford-Hutchinson A. W., Bray M. A. Leukotriene B4: a potential mediator of inflammation. J Pharm Pharmacol 1980; 32: 517-518.
24. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568-575.
25. Rola-Plezczynski M. Immunoregulation by leukotrienes and other lipoxygenase metabolites. Immunol Today 1985; 6: 302-307.
26. Claesson H. E., Dahlberg N., Gahrton G. Stimulation of human myelopoiesis by leukotriene B4. Biochem Biophys Res Commun 1985; 131: 579-585.
27. Rola-Pleszczynsk M., Sirois B. LTB4 induces human suppressor lymphocytes. Biochem Biophys Res Commun 1982; 108: 1531-1537.
28. 4 plus IL-2 generate CD8+ suppressor thymocytes involved in tolerance to self. Thymus 1991; 18: 111-128.
29. Rola-Pleszczynski M. L., Gagnon M., Sirois P. Leukotriene B4 augments human natural cytotoxic cell activity. Biochem Biophys Res Commun 1983; 113: 531-537
30. γ production by LTB4 in human lymphocyte cultures. Prostaglandin Leukot Med 1986; 23: 207-210.
31. Yamaoka K. A., Claesson H. E., Rosen A. LTB4 enhances activation, proliferation and differentiation of human B lymphocytes. J Immunol 1989; 143: 1996-2000.
32. Gualde N., Atluru D., Goodwin J. S. Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cell and T cell subsets. J Immunol 1985; 134: 1125-1129.
33. Walsh C. E., Waite B. M., Thomas M. J., DeChalet L. R. Release and metabolism of arachidonic acid in human neutrophils. J Biol Chem 1981; 256: 7228-7234.
34. Ford-Hutchinson A. W., Bray M. A., Doig M. V., Shipley M. E., Smith M. J. H. Leukotriene B4: a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980; 286: 264-265.
35. Martin T. R., Altman L. C., Albert R. K., Henderson W. R. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis 1984; 129: 106-111.
36. Rabinovitch H., Durand J., Gualde N., Rigaud M. Metabolism of polyunsaturated fatty acids by mouse peritoneal macrophages: the lipoxygenase metabolic pathway. Agents Actions 1981; 11: 580-583.
37. Vore S. J., Eling T. E., Danilowicz M., Tucker A. N., Luster M. I. Regulation of murine hematopoiesis by arachidonic acid metabolltes. Int J Immunopharmacol 1989; 11: 435-442.
38. Dupuis F., Desplat V., Praloran V., Denizot Y. Effects of lipidic mediators on the growth of human myeloid and erythoid marrow progenitors. J Lipid Mediators Cell Signaling 1997; 16: 117-125.
39. Denizot Y., Trimoreau F., Dupuis F., Verger C., Praloran V. PAF and hematopoiesis. III. Presence and metabolism of plateleted-activating factor by human bone marrow. Biochim Biophys Acta 1995; 1265: 55-60.
40. Nakayama Y., Shindo T., Akihama T., Miura A. B. Prostaglandin E2 production by human bone marrow cells: a comparison with peripheral blood mononuclear cells. J Exp Med 1984; 144: 417-423.
41. Lindgren J. A., Stenke L., Mansour M., Edenius C., Lauren L., Nasman-Glaser B., Ericsson I., Reizeinstein B. Formation and effects of leukotrienes and lipoxins in human bone marrow. J Lipid Med 1993; 6: 313-320.
42. Stenke S., Lauren L., Reizeinstein P., Lindgren J. A. Leukotriene production by fresh human bone marrow cells: evidence of altered lipoxygenase activity in chronic myelocytic leukemia. Exp Hematol 1987; 15: 203-207.
43. Ruzika T., Aubock J. Arachidonic acid metabolism in guinea pig Langerhans cells: studies on cyclooxygenase and lipoxygenase pathways. J Immunol 1987; 138: 539-543.
44. Spambroek R., Stark H. J., Jassen-Timmen U., Kraft S., Hilder M., Andl T., Bosch F. X., Fusenig N. E., Bieber T., Radmark O., Samuelsson B., Habenicht A. J. 5-Lipoxygenase expression in Langerhans cells of normal human epidermis. Proc Natl Acad Sci USA 1998; 95: 663-668.
45. + hematopoietic progenitors and in lymphoid organs. Blood 2000; 96: 3857-3865.
46. Coulon V., Ravaud A., Huet S., Gualde G. In vitro production of human antigen-presenting cells issued from the bone marrow of patients with cancer. Hematol Cell Ther 1997; 39: 237-244.
47. Coulon V., Ravaud A., Gaston R., Delaunay M. M., Pariente J. L., Verdier D., Scrivante V., Gualde N. In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor cell lysates. Int J Cancer 2000; 88: 783-790.
48. Matiasic R., Dietz A. B., Vuc-Pavlovic S. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology 2000; 101: 53-60.
49. Gierse J. K., McDonald J. J., Hauser S. D., Rangwala S. H., Koboldt C. M., Seibert K. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2-specffic inhibitors. J Biol Chem 1994; 271: 15 810-15 81.4
50. Meade E. A., Smith W. L., Dewitt D. L. Differential inhibition of prostaglandin endoperoxyde synthase (cyclooxygenase) isoenzyme by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610-6614.
51. Kurumbail R. G., Stevens A. M., Gierse J. K. Structural basis of selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996; 384: 644-648.
52. Gentille P. S., Pelus L. M. In vitro modulation of myelopoiesis by PGE2. Inhibition of granulocyte-monocyte progenitors cell (CFU-GM) cell cycle rate. Exp Hematol 1987; 15: 119-126.
53. Shibata Y, Burdick M. K., Bjorkman D. R., Volkman A. A regulatory role of PGE2-activated adhesion molecules in myelopoiesis. Adv Exp Med Biol 1997; 400B: 741-749.
54. Nusing R. M., Barsig J. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by avtivin A. Br J Pharmacol 1999; 127: 919-926.
55. Hempel S. L., Monick M. M., Hunninghake G. W. Lipoplysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 1994; 93: 391-396.
56. Seibert K., Zhang Y., Leahy K., Hausert S., Masferrer J., Perkins J, Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase-2 in inflammation and pain. Proc Natl Acad Sci USA 1994; 91: 12013-12017.
57. Masferrer J., Zweffel L. B., Manning P. T., Hauser S. D., Leahy K. M., Smith G. W., Seibert K. Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994; 91: 3228-3232.
58. Snyder D. S., Beller D. L., Unanue E. R. Prostaglandins modulates macrophage Ia expression. Nature 1982; 299: 163-165.